Cargando…
N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19) and can be associated with serious complications, including acute respiratory distress syndrome. This condition is accompanied by a massive release of cytokines, also denominated cytokin...
Autores principales: | Izquierdo-Alonso, José Luis, Pérez-Rial, Sandra, Rivera, Carolina Gotera, Peces-Barba, Germán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651994/ https://www.ncbi.nlm.nih.gov/pubmed/36410267 http://dx.doi.org/10.1016/j.jiph.2022.11.009 |
Ejemplares similares
-
Current developments and future directions in COPD
por: Mathioudakis, Alexander G., et al.
Publicado: (2020) -
COPD is commonly underdiagnosed in patients with lung cancer: results from the RECOIL study (retrospective study of COPD infradiagnosis in lung cancer)
por: Parrón Collar, Dámaso, et al.
Publicado: (2017) -
N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence
por: Ooi, Soo Liang, et al.
Publicado: (2018) -
Role of Recently Migrated Monocytes in Cigarette Smoke-Induced Lung Inflammation in Different Strain of Mice
por: Pérez-Rial, Sandra, et al.
Publicado: (2013) -
Proliferative Activity of Liver Growth Factor is Associated with an Improvement of Cigarette Smoke-Induced Emphysema in Mice
por: Girón-Martínez, Álvaro, et al.
Publicado: (2014)